Skip to content
OpenCapital
Get started

Ingevity NGVT Additional Paid-In Capital

Additional Paid-In Capital at other companies

Cabot Corporation logo
Cabot CorporationCBT
$1M-95.8%
PPG Industries logo
PPG IndustriesPPG
$1.35B+4.4%
Sherwin-Williams logo
Sherwin-WilliamsSHW
$4.28B-7.5%
Chemours logo
ChemoursCC
$1.08B+2.0%
Avient logo
AvientAVNT
$1.54B+0.3%
Innospec logo
InnospecIOSP
$377.3M+1.8%

Other financials

Income statement

See full
Revenue$258.0M+4.1%
Gross profit$116.4M+4.0%
Net income$59.8M+192%
EPS (diluted)$1.66+196%

Balance sheet

See full
Cash & equivalents$95.4M+5.0%
Total debt$1.4B-9.0%
Total equity$38.9M-83.4%
Total assets$1.7B-19.7%

Cash flow

See full
Operating cash flow-$2.0M-108%
CapEx$10.3M+3.0%
Free cash flow-$12.3M-180%

Valuation

See full
Market cap$2.53B+73.9%
Enterprise value$3.8B+32.4%
P/S2.1×+0.9×

Profitability

See full
Gross margin39.3%+1.5pp
Net margin-10.6%-4.1pp
FCF margin20.3%+12.6pp

Returns & leverage

See full
Return on equity-93.5%+1.2pp
Debt / equity35.1×+28.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingevity's additional paid-in capital?
Ingevity (NGVT) reported additional paid-in capital of $203.4M in Q1 2026.
How has Ingevity's additional paid-in capital changed year-over-year?
Ingevity's additional paid-in capital increased by 12.4% year-over-year, from $180.9M to $203.4M.
What is the long-term trend for Ingevity's additional paid-in capital?
Over 5 years (2020 to 2025), Ingevity's additional paid-in capital has grown at a 10.0% compound annual growth rate (CAGR), from $121.3M to $195.7M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.